| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780127 | Gynecologic Oncology | 2018 | 9 Pages |
Abstract
Among chemotherapy-treated ovarian cancer patients, SPN levels were stable over time. In contrast, MPN symptoms significantly improved at 12Â months. These symptoms seriously impacted HRQoL. Future studies should examine the impact of different treatment decisions and alterations on CIPN, so recommendations can be made to reduce CIPN (prevalence).
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Cynthia S. Bonhof, Floortje Mols, M. Caroline Vos, Johanna M.A. Pijnenborg, Dorry Boll, Gerard Vreugdenhil, Nicole P.M. Ezendam, Lonneke V. van de Poll-Franse,